These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis. Chai JL, Roller LA, Liu X, Lan Z, Mossanen M, Silverman SG, Shinagare AB. Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214 [Abstract] [Full Text] [Related]
8. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application. Makboul M, Farghaly S, Abdelkawi IF. Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328 [Abstract] [Full Text] [Related]
13. Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions. Arita Y, Shigeta K, Akita H, Suzuki T, Kufukihara R, Kwee TC, Ishii R, Mikami S, Okuda S, Kikuchi E, Oya M, Jinzaki M. Eur Radiol; 2021 Feb; 31(2):875-883. PubMed ID: 32829418 [Abstract] [Full Text] [Related]
14. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System. Arita Y, Kwee TC, Woo S, Shigeta K, Ishii R, Okawara N, Edo H, Waseda Y, Vargas HA. Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790 [Abstract] [Full Text] [Related]
15. Detecting Muscle Invasion of Bladder Cancer Using a Proposed Magnetic Resonance Imaging Strategy. Wang X, Tu N, Sun F, Wen Z, Lan X, Lei Y, Cui E, Lin F. J Magn Reson Imaging; 2021 Oct; 54(4):1212-1221. PubMed ID: 33998725 [Abstract] [Full Text] [Related]
17. Visual MRI T-category versus VI-RADS evaluation from multiparametric MRI in the detection of muscle-invasion in patients with suspected bladder cancer: single centre registered clinical trial (MIB-trial). Nikulainen I, Salminen AP, Jambor I, Merisaari H, Tammilehto V, Taimen P, Seikkula H, Boström PJ. Scand J Urol; 2021 Oct; 55(5):354-360. PubMed ID: 34448679 [Abstract] [Full Text] [Related]
19. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, Huddart R, Kennish S, Lerner S, Montironi R, Muglia VF, Salomon G, Thomas S, Vargas HA, Witjes JA, Takeuchi M, Barentsz J, Catto JWF. Eur Urol; 2018 Sep; 74(3):294-306. PubMed ID: 29755006 [Abstract] [Full Text] [Related]
20. Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Woo S, Panebianco V, Narumi Y, Del Giudice F, Muglia VF, Takeuchi M, Ghafoor S, Bochner BH, Goh AC, Hricak H, Catto JWF, Vargas HA. Eur Urol Oncol; 2020 Jun; 3(3):306-315. PubMed ID: 32199915 [Abstract] [Full Text] [Related] Page: [Next] [New Search]